Drug intelligence / Profile preview

L-Vincristine

Development stage
Preclinical
Lead developer
InnoMedica
Modality
Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

L-Vincristine is a preclinical-stage liposomal nanocarrier formulation of vincristine being developed by InnoMedica Holding AG for the treatment of leukemia. The drug utilizes InnoMedica's proprietary liposomal nanocarrier technology platform to deliver the active ingredient vincristine, a vinca alkaloid chemotherapy agent. Vincristine works by disrupting microtubule formation during cell division, specifically by binding to tubulin and inhibiting its polymerization, making it effective against rapidly dividing cancer cells. The liposomal formulation is designed to improve drug delivery and potentially reduce the dose-limiting neurotoxicity associated with conventional vincristine while maintaining or enhancing therapeutic efficacy.

Other names
vincristine liposomal nanocarrierliposomal vincristine
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on L-Vincristine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-Vincristine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call